MOJ Clinical & Medical Case Reports, Journal Year: 2024, Volume and Issue: 14(4), P. 105 - 107
Published: Jan. 1, 2024
Language: Английский
MOJ Clinical & Medical Case Reports, Journal Year: 2024, Volume and Issue: 14(4), P. 105 - 107
Published: Jan. 1, 2024
Language: Английский
MedComm – Future Medicine, Journal Year: 2024, Volume and Issue: 3(4)
Published: Dec. 1, 2024
Abstract Muscle atrophy, characterized by the loss of muscle mass and function, is a hallmark sarcopenia cachexia, frequently associated with aging, malignant tumors, chronic heart failure, malnutrition. Moreover, it poses significant challenges to human health, leading increased frailty, reduced quality life, heightened mortality risks. Despite extensive research on consensus in their assessment remains elusive, inconsistent conclusions regarding molecular mechanisms. atrophy models are crucial tools for advancing this field. Currently, animal used clinical basic scientific studies induced through various methods, including genetic editing, nutritional modification, exercise, wasting diseases, drug administration. also include vitro small organism models. value, each these has certain limitations. This review focuses limitations diverse applications understand encourage rational use future research, therefore deepening understanding underlying pathophysiological mechanisms, ultimately exploration therapeutic strategies cachexia.
Language: Английский
Citations
0MOJ Clinical & Medical Case Reports, Journal Year: 2024, Volume and Issue: 14(4), P. 105 - 107
Published: Jan. 1, 2024
Language: Английский
Citations
0